Search Results

Researchers have found that with increasing popularity of GLP-1 drugs, their consumption has significantly increased among those with no FDA approved indications

The study will begin enrolling eligible patients in September. Thirty participants, ages 12 and older, will be randomized to receive either a placebo or the GLP-1 receptor agonist semaglutide

Roswell Park reveals that exercise was linked to fewer immune-suppressing cells and greater tumor-fighting activity in preclinical and patient samples.

New research reveals that stress-responsive brain cells may influence obesity through opposing effects of CRH and glutamate.

A new global study links falling testosterone to obesity and metabolic syndrome. Here's the science, and expert guidance for men

New policy recommendations focus on healthier food environments, front-of-pack labels, school canteens, and restrictions on marketing unhealthy foods to children